# Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients

> **NCT01551212** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 339 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Tacrolimus
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT01551212
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-24
- **Primary completion:** 2017-08-08
- **Final completion:** 2017-08-08
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2019-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551212, "Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01551212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*